FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Amphetamine Aspartate; Amphetamine Sulfate; Dextroamphetamine Saccharate; Dextroamphetamine Sulfate Tablets
Status: Currently in Shortage
»Date first posted: 09/12/2019
»Therapeutic Categories: Psychiatry

Expand all

Aurobindo Pharma (Reverified 09/07/2021)

Company Contact Information:
732-839-9400

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Amphetamine Mixed Salts Tablets C-II 5 mg, 100 (NDC 13107-0068-01) Available Demand increase for the drug
Amphetamine Mixed Salts Tablets C-II 10 mg, 100 (NDC 13107-0070-01) Available Demand increase for the drug
Amphetamine Mixed Salts Tablets C-II 15 mg, 100 (NDC 13107-0072-01) Available Demand increase for the drug
Amphetamine Mixed Salts Tablets C-II 20 mg, 100 (NDC 13107-0073-01) Available Demand increase for the drug
Amphetamine Mixed Salts Tablets C-II 30 mg, 100 (NDC 13107-0074-01) Available Demand increase for the drug

Mylan Pharmaceuticals Inc., a Viatris Company (Reverified 09/16/2021)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5mg [1.25/1.25/1.25/1.25mg] 100s (NDC 0378-4541-01) Out of Stock/Unavailable Other
7.5mg [1.875/1.875/1.875/1.875mg] 100s (NDC 0378-4542-01) Out of Stock/Unavailable Other
10mg [2.5/2.5/2.5/2.5mg] 100s (NDC 0378-4543-01) Out of Stock/Unavailable Other
12.5mg [3.125/3.125/3.125/3.125mg] 100s (NDC 0378-4544-01) Out of Stock/Unavailable Other
15mg [3.75/3.75/3.75/3.75mg] 100s (NDC 0378-4545-01) Out of Stock/Unavailable Other
20mg [5/5/5/5mg] 100s (NDC 0378-4546-01) Out of Stock/Unavailable Other
30mg [7.5/7.5/7.5/7.5mg] 100s (NDC 0378-4547-01) Out of Stock/Unavailable Other

Sandoz (Reverified 08/31/2021)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
30 mg, 100 Count Bottle (NDC 0185-0864-01) Available Demand increase for the drug
20 mg, 100 Count Bottle (NDC 0185-0853-01) Available Demand increase for the drug
10 mg, 100 Count Bottle (NDC 0185-0842-01) Available Demand increase for the drug
5 mg, 100 Count Bottle (NDC 0185-0831-01) Available Demand increase for the drug

Teva Pharmaceuticals (Revised 09/03/2021)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Adderall(R) Tablets 10mg 100 (NDC 57844-0110-01) Available
Adderall(R) Tablets 12.5mg 100 (NDC 57844-0112-01) Available
Adderall(R) Tablets 15mg 100 (NDC 57844-0115-01) Available
Adderall(R) Tablets 20mg 100 (NDC 57844-0120-01) Currently unavailable. Expected resupply end of September and product recovery October 2021
Adderall(R) Tablets 30mg 100 (NDC 57844-0130-01) Available
Adderall(R) Tablets 5mg 100 (NDC 57844-0105-01) Available
Adderall(R) Tablets 7.5mg 100 (NDC 57844-0117-01) Available
12.5 mg 100 count (NDC 0555-0776-02) Available
15 mg 100 count (NDC 0555-0777-02) Available
7.5 mg 100 count (NDC 0555-0775-02) Available
10 mg 100 count (NDC 0555-0972-02) Available
20 mg 100 count (NDC 0555-0973-02) Available
30 mg 100 count (NDC 0555-0974-02) Available
5 mg 100 count (NDC 0555-0971-02) Available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English